Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies.
暂无分享,去创建一个
Despina Sanoudou | D. Sanoudou | E. Kranias | D. Arvanitis | A. Kontrogianni-Konstantopoulos | Aikaterini Kontrogianni-Konstantopoulos | Evangelia Kranias | Demetrios A Arvanitis | E. Vafiadaki | Elizabeth Vafiadaki
[1] L. Hawthorn,et al. Decreased SLIM1 Expression and Increased Gelsolin Expression in Failing Human Hearts Measured by High-Density Oligonucleotide Arrays , 2000, Circulation.
[2] J. Marx. How to Subdue a Swelling Heart , 2003, Science.
[3] W. Abraham,et al. Ischemic and nonischemic heart failure do not require different treatment strategies. , 1999, Journal of cardiovascular pharmacology.
[4] James O. Mudd,et al. An abnormal Ca(2+) response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy. , 2000, The Journal of clinical investigation.
[5] N. Green,et al. Amino-acid sequence of a Ca2++Mg2+-dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence , 1985, Nature.
[6] Stephen M. Hewitt,et al. Post-analysis follow-up and validation of microarray experiments , 2002, Nature Genetics.
[7] R. Nichols,et al. Application of DNA microarrays to study the evolutionary genomics of Yersinia pestis and Yersinia pseudotuberculosis. , 2003, Genome research.
[8] N. Iizuka,et al. MECHANISMS OF DISEASE Mechanisms of disease , 2022 .
[9] R. Denton,et al. The role of Ca2+ ions in the regulation of intramitochondrial metabolism and energy production in rat heart , 1989, Molecular and Cellular Biochemistry.
[10] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[11] C. Ogilvie,et al. Strategies for the rapid prenatal diagnosis of chromosome aneuploidy , 2004, European Journal of Human Genetics.
[12] L. Peltonen,et al. Inherited idiopathic dilated cardiomyopathy with multiple deletions of mitochondrial DNA , 1992, The Lancet.
[13] Eric S. Lander,et al. Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse , 2000, Nature Genetics.
[14] F. Penault-Llorca,et al. DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection. , 2004, Molecular human reproduction.
[15] J. Hill,et al. Role of Metabolically Active Drugs in the Management of Ischemic Heart Disease , 2001, American journal of cardiovascular drugs : drugs, devices, and other interventions.
[16] K. Chien,et al. Complexity in simplicity: monogenic disorders and complex cardiomyopathies. , 1999, The Journal of clinical investigation.
[17] A. Butte,et al. Discovering functional relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[18] J. Towbin,et al. Molecular diagnosis of myocardial disease , 2002, Expert review of molecular diagnostics.
[19] P. Kang,et al. Apoptosis and heart failure: A critical review of the literature. , 2000, Circulation research.
[20] Eric P. Hoffman,et al. Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology , 2000 .
[21] G. Taffet,et al. The absence of desmin leads to cardiomyocyte hypertrophy and cardiac dilation with compromised systolic function. , 1999, Journal of molecular and cellular cardiology.
[22] S. Neubauer,et al. Effects of ACE inhibition and β-receptor blockade on energy metabolism in rats postmyocardial infarction. , 1999, American journal of physiology. Heart and circulatory physiology.
[23] F. Gallyas,et al. Protective Effect of Amiodarone but Not N- Desethylamiodarone on Postischemic Hearts through the Inhibition of Mitochondrial Permeability Transition , 2003, Journal of Pharmacology and Experimental Therapeutics.
[24] M. Givertz. Underlying causes and survival in patients with heart failure. , 2000, The New England journal of medicine.
[25] Y. Capetanaki. Desmin cytoskeleton: a potential regulator of muscle mitochondrial behavior and function. , 2002, Trends in cardiovascular medicine.
[26] J. Towbin,et al. X‐Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy (Dystrophin) Gene at the Xp21 Locus , 1993, Circulation.
[27] Kenji Nakamura,et al. Cardiac fibrosis in mice lacking brain natriuretic peptide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[28] D. Pakstis,et al. Coronary angiography results have minimal impact on use of lipid-lowering agents in women: pilot phase data from WISE , 1998 .
[29] D. Stamatiou,et al. Construction of a human cardiovascular cDNA microarray: portrait of the failing heart. , 2001, Biochemical and biophysical research communications.
[30] H. Katus,et al. Frequency and phenotypes of familial dilated cardiomyopathy. , 1998, Journal of the American College of Cardiology.
[31] Huiling He,et al. Microarray Analysis Uncovers the Induction of the Proapoptotic BH3-only Protein Bim in Multiple Models of Glucocorticoid-induced Apoptosis* , 2003, Journal of Biological Chemistry.
[32] Ulrike Mende,et al. Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban , 2003, Science.
[33] L. Fananapazir,et al. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy. , 2000, Journal of molecular and cellular cardiology.
[34] M. Anderson. Calmodulin kinase and L-type calcium channels; a recipe for arrhythmias? , 2004, Trends in cardiovascular medicine.
[35] Maestri,et al. The Failing Heart. , 1997, Advances in clinical pathology : the official journal of Adriatic Society of Pathology.
[36] Atul J. Butte,et al. Reproducibility of gene expression across generations of Affymetrix microarrays , 2003, BMC Bioinformatics.
[37] Jason E. Stewart,et al. Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.
[38] J. Cohn,et al. Definition, classification, and staging of the adult cardiomyopathies: a proposal for revision. , 2004, Journal of cardiac failure.
[39] T. Speed,et al. Design issues for cDNA microarray experiments , 2002, Nature Reviews Genetics.
[40] M B Eisen,et al. Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[41] T. Eulgem,et al. The transcriptome of Arabidopsis thaliana during systemic acquired resistance , 2000, Nature Genetics.
[42] F. Waagstein,et al. Spectrum and outcome of congestive heart failure in a hospitalized population. , 1993, American heart journal.
[43] Man-Weichung,et al. Hypertrophic cardiomyopathy:from gene defect to clinical disease , 2003 .
[44] Minoru Hongo,et al. MLP-Deficient Mice Exhibit a Disruption of Cardiac Cytoarchitectural Organization, Dilated Cardiomyopathy, and Heart Failure , 1997, Cell.
[45] L. Kunkel,et al. Molecular profiles of inflammatory myopathies , 2002, Neurology.
[46] C. Hsiung,et al. Coupling multiplex RT-PCR to a gene chip assay for sensitive and semiquantitative detection of severe acute respiratory syndrome-coronavirus , 2004, Laboratory Investigation.
[47] L. Tavazzi,et al. Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. , 2000, Journal of the American College of Cardiology.
[48] Ken Garber,et al. Gene Expression Tests Foretell Breast Cancer's Future , 2004, Science.
[49] Y. J. Kang. The antioxidant function of metallothionein in the heart. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[50] P. Cin,et al. Molecular pathogenesis of uterine smooth muscle tumors from transcriptional profiling , 2004, Genes, chromosomes & cancer.
[51] E. Sonnenblick,et al. Fibroblast proliferation during myocardial development in rats is regulated by IGF-1 receptors. , 1995, The American journal of physiology.
[52] P. du Souich,et al. Effect of hypoxia on cytochrome P450 activity and expression. , 2004, Current drug metabolism.
[53] Carl Virtanen,et al. Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles , 2004, The Lancet.
[54] P. Brown,et al. Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[55] T. Tsunoda,et al. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. , 2001, Cancer research.
[56] D. Fatkin,et al. Molecular mechanisms of inherited cardiomyopathies. , 2002, Physiological reviews.
[57] A. Trounson,et al. Towards preimplantation diagnosis of cystic fibrosis using microarrays. , 2004, Reproductive biomedicine online.
[58] G. Francis. Changing the remodeling process in heart failure: basic mechanisms and laboratory results. , 1998, Current opinion in cardiology.
[59] H. Watkins,et al. Properties of mutant contractile proteins that cause hypertrophic cardiomyopathy. , 1999, Cardiovascular Research.
[60] A. Tajik,et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. , 1992, The New England journal of medicine.
[61] G. Dorn,et al. Cardiac-specific Overexpression of Mouse Cardiac Calsequestrin Is Associated with Depressed Cardiovascular Function and Hypertrophy in Transgenic Mice* , 1998, The Journal of Biological Chemistry.
[62] S. Solomon,et al. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy. , 2001, The New England journal of medicine.
[63] E. Kranias,et al. Sarcoplasmic reticulum Ca-ATPase-phospholamban interactions and dilated cardiomyopathy. , 2004, Biochemical and biophysical research communications.
[64] E. Maestrini,et al. A novel X-linked gene, G4.5. is responsible for Barth syndrome , 1996, Nature Genetics.
[65] J. Gruen,et al. Peaks of linkage are localized by a BAC/PAC contig of the 6p reading disability locus. , 2001, Genomics.
[66] A. de Haan,et al. Calcium regulation and muscle disease , 2004, Journal of Muscle Research & Cell Motility.
[67] J. Gardin,et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. , 1995, Circulation.
[68] Javed Khan,et al. Diagnostic Classification of Cancer Using DNA Microarrays and Artificial Intelligence , 2004, Annals of the New York Academy of Sciences.
[69] E. Olson. A decade of discoveries in cardiac biology , 2004, Nature Medicine.
[70] R. Moreno-Sánchez,et al. Heart metabolic disturbances in cardiovascular diseases. , 2003, Archives of medical research.
[71] R. Lempicki,et al. Evaluation of gene expression measurements from commercial microarray platforms. , 2003, Nucleic acids research.
[72] M. Dunn,et al. Heart failure and apoptosis: Electrophoretic methods support data from micro‐ and macro‐arrays. A critical review of genomics and proteomics , 2001, Proteomics.
[73] D. Bell. Heart failure: the frequent, forgotten, and often fatal complication of diabetes. , 2003, Diabetes care.
[74] G. Dorn,et al. Genetic Causes of Cardiac Hypertrophy Divergent Transcriptional Responses to Independent , 2022 .
[75] S. Henderson,et al. Kaposi sarcoma herpesvirus–induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma , 2004, Nature Genetics.
[76] A. Chan,et al. Effect of cocaine on cardiac biochemical functions. , 1999, Journal of cardiovascular pharmacology.
[77] T. Pearson,et al. The American College of Cardiology Evaluation of Preventive Therapeutics (ACCEPT) study: attainment of goals for comprehensive risk reduction in patients with coronary disease in the US , 1998 .
[78] L. Mestroni,et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. , 1999, Journal of the American College of Cardiology.
[79] G. Baxter,et al. Autocrine and paracrine actions of natriuretic peptides in the heart. , 2004, Pharmacology & therapeutics.
[80] D. Ingber,et al. Mechanotransduction across the cell surface and through the cytoskeleton , 1993 .
[81] R. Schwinger,et al. Modulation of SERCA: implications for the failing human heart , 2002, Basic Research in Cardiology.
[82] Raimond L Winslow,et al. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. , 2004, Genomics.
[83] Partha S. Vasisht. Computational Analysis of Microarray Data , 2003 .
[84] L. Pickle,et al. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. , 1984, The American journal of cardiology.
[85] N. Green,et al. Amino-acid sequence of a Ca2+ + Mg2+ -dependent ATPase from rabbit muscle sarcoplasmic reticulum, deduced from its complementary DNA sequence , 1985, Nature.
[86] F. Follath,et al. Nonischemic heart failure: epidemiology, pathophysiology, and progression of disease. , 1999, Journal of cardiovascular pharmacology.
[87] H. Vosberg,et al. Low‐density DNA microarrays are versatile tools to screen for known mutations in hypertrophic cardiomyopathy , 2002, Human mutation.
[88] J. Cleland,et al. Heart failure due to ischaemic heart disease: epidemiology, pathophysiology and progression. , 1999, Journal of cardiovascular pharmacology.
[89] J. Seidman,et al. The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.
[90] James O. Mudd,et al. An abnormal Ca2+ response in mutant sarcomere protein–mediated familial hypertrophic cardiomyopathy , 2000 .
[91] S. Thibodeau,et al. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. , 1998, Science.
[92] P. Brown,et al. A specific gene expression program triggered by Gram-positive bacteria in the cytosol. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[93] E. Nabel. Cardiovascular disease , 2000, Nature Biotechnology.
[94] Jianbo Li,et al. The gene expression fingerprint of human heart failure , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[95] M. Cremer,et al. Association of nonsense mutation of dystrophin gene with disruption of sarcoglycan complex in X-linked dilated cardiomyopathy , 2000, The Lancet.
[96] E. Wolski,et al. Normalization strategies for cDNA microarrays. , 2000, Nucleic acids research.
[97] E. Lander,et al. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease , 2003, Nature Genetics.
[98] Isaac S Kohane,et al. Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[99] C. Scharff,et al. Gene Expression Changes in the Course of Neural Progenitor Cell Differentiation , 2022 .
[100] J. Prestle,et al. Ca(2+)-handling proteins and heart failure: novel molecular targets? , 2003, Current medicinal chemistry.
[101] N. Bowles,et al. Genetics of inherited cardiomyopathies , 2004, Expert review of cardiovascular therapy.
[102] L. Mestroni,et al. Clinical StudiesFamilial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity☆ , 1999 .
[103] N. Weissman,et al. Remodelling of ionic currents in hypertrophied and failing hearts of transgenic mice overexpressing calsequestrin , 2000, The Journal of physiology.
[104] H. Katus,et al. Cardiomyopathies: from genetics to the prospect of treatment , 2001, The Lancet.
[105] L. Mestroni,et al. Familial dilated cardiomyopathy: evidence for genetic and phenotypic heterogeneity. Heart Muscle Disease Study Group. , 1999, Journal of the American College of Cardiology.
[106] P. Bornstein,et al. Regulation of collagen gene expression. , 1989, Progress in nucleic acid research and molecular biology.
[107] L. Melton,et al. Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. , 1989, Circulation.
[108] Robert Tibshirani,et al. Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes. , 2004, Blood.
[109] M. Bittner,et al. Expression profiling using cDNA microarrays , 1999, Nature Genetics.
[111] F. Spinale,et al. Controlling myocardial matrix remodeling: implications for heart failure. , 1999, Cardiology in review.
[112] J. Towbin,et al. 1854 X-Linked Dilated Cardiomyopathy Molecular Genetic Evidence of Linkage to the Duchenne Muscular Dystrophy ( Dystrophin ) Gene at the Xp 21 Locus , 2005 .
[113] N. Maulik,et al. Apoptosis, Heart Failure, Ischemic Heart Disease , 1999, Heart Failure Reviews.
[114] Petri Auvinen,et al. Are data from different gene expression microarray platforms comparable? , 2004, Genomics.
[115] I. Kohane,et al. Molecular classification of nemaline myopathies: “nontyping” specimens exhibit unique patterns of gene expression , 2004, Neurobiology of Disease.
[116] S. Tyagi,et al. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. , 1999, Journal of hypertension.
[117] K. Deisseroth,et al. Calmodulin supports both inactivation and facilitation of L-type calcium channels , 1999, Nature.
[118] G. Dorn,et al. Human phospholamban null results in lethal dilated cardiomyopathy revealing a critical difference between mouse and human. , 2003, The Journal of clinical investigation.
[119] L. Mestroni,et al. A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. , 1995, The Journal of clinical investigation.
[120] T. Borg,et al. Specialization at the Z line of cardiac myocytes. , 2000, Cardiovascular research.
[121] N. Alpert,et al. Human heart failure: dilated versus familial hypertrophic cardiomyopathy. , 2003, Advances in experimental medicine and biology.
[122] K. Chien. Genomic circuits and the integrative biology of cardiac diseases , 2000, Nature.
[123] Tsz-Kwong Man,et al. Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA. , 2004, Nucleic acids research.
[124] V. Beneš,et al. Standardization of protocols in cDNA microarray analysis. , 2003, Trends in biochemical sciences.
[125] R. Ferrari,et al. Oxidative stress in cardiovascular disease: myth or fact? , 2003, Archives of biochemistry and biophysics.
[126] Paul D Allen,et al. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. , 2002, The American journal of pathology.
[127] Francisco H Andrade,et al. Constitutive properties, not molecular adaptations, mediate extraocular muscle sparing in dystrophic mdx mice , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[128] T. Thum,et al. Gene expression in distinct regions of the heart , 2000, The Lancet.
[129] W. Parmley,et al. Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts , 1995, Cardiovascular Drugs and Therapy.
[130] George C Tseng,et al. Microarray gene expression profiles in dilated and hypertrophic cardiomyopathic end-stage heart failure. , 2002, Physiological genomics.
[131] J. D. Porter,et al. A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice. , 2002, Human molecular genetics.
[132] M. Le Cunff,et al. Transcriptomal analysis of failing and nonfailing human hearts. , 2003, Physiological genomics.
[133] I. Jurisica,et al. Molecular classification of oral cancer by cDNA microarrays identifies overexpressed genes correlated with nodal metastasis , 2004, International journal of cancer.